NovoCure Ltd. (NVCR) at a glance

NovoCure Ltd. (NVCR) is a Healthcare company. It trades at $17.65. It does not pay a dividend. Vestovix scores it 53/100 overall. Its strongest dimension is Momentum (77/100) and its weakest is Income (40/100).

Price
$17.65
Market cap
n/a
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$9.82 to $18.92
Vestovix Score53/ 100How this works
Value
50
Growth
50
Income
40
Safety
60
Momentum
77